How to master global teams for product development Best practices for aligning cross-functional and international teams to ensure streamlined workflows and communication in the product development lifecycle Exploring how to transform regulatory insights into actionable strategies that enhance global product development, reduce risks, and meet compliance requirements Understanding emerging regulatory trends globally and their potential impact on medical device innovation,…
Key impacts of EU Medical Device Regulation (MDR) on product development and quality Recertification timelines and strategies for seamless compliance Navigating new post-market surveillance requirements Short and long-term implications of MDR on market access Gaining a competitive edge by proactively aligning with MDR standards
Driving impact in musculoskeletal health through strategic P&L management Crafting digital health ecosystems for enhanced patient and caregiver experiences Navigating data strategy complexities in the expansive healthcare ecosystem Overcoming challenges and ensuring compliance in the rapidly evolving industry landscape
As AI continues to drive innovation in medical devices, understanding and navigating the evolving regulatory frameworks in both the United States and Europe has become essential Exploring how the FDA has approached AI-based device submissions over the past 12 years, including recent experiences with the FDA’s ELSA platform, and contrasts this with the emerging regulatory structure of the EU AI…
The latest threats and risks in healthcare devices and disposables Common challenges including counterfeiting and unauthorized reuse or refurbishment The role of security chips in MedTech designs: Threat models and regulatory requirements Security ICs and their applications in healthcare devices and supply chains
Computational models can predict real-world behavior, optimize complex designs, and reduce the need for physical prototypes Benefits include enhanced quality, patient safety, brand reputation and faster time-to-market In silico clinical trials can reduce/refine/replace clinical trials in humans Regulatory acceptance and global harmonization are supporting adoption by medical device/drug companies
Evaluating business processes to uncover AI-driven efficiency opportunities Identifying and select the right AI tools for MedTech Strategically deploy AI solutions aligned with company goals Training teams to effectively adopt and use AI tools Driving long-term value through smart AI integration and support
Advancing disease detection with AI for faster, more accurate diagnosis Streamlining workflows to reduce costs, increase productivity, and optimize operations Personalizing treatments by analyzing patient data for more effective therapies Navigating evolving AI/ML regulations while balancing innovation and compliance Leveraging emerging AI technologies to drive breakthroughs in diagnostics and supply chain
